Hospice News April 24, 2024
Amedisys Inc. (NASDAQ: AMED) has seen gains in its hospice segment as it waits for closure on its pending acquisition by Optum.
The company’s hospice segment brought in $201 million in the first quarter of the year, up from $193.4 million year over year. Cost per day rose 2.3% during the quarter, however, largely due to wage inflation, according to an earnings release.
Optum, a subsidiary of UnitedHealth Group (NYSE: UHN), in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion.
“We are excited about this opportunity with Optum – it’s a win for everyone, especially patients who need our services,” Amedisys CEO Richard Ashworth said in a video sent...
Today's Sponsors
Today's Sponsor